PIK3C2A and myositis disease: The first had a CPK peak value (17,690 UI/L) significantly higher than the median values of the cohort with a normalization time significantly longer (8 days) than the others; the second, with RYR1 mutation and COVID infection, had a history of two previous episodes of myositis.